Mineral Oil Heavy

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Mineral Oil Heavy
Generic name: MINERAL OIL
Manufacturer: Pharma Nobis, LLC
Product type: HUMAN OTC DRUG
SPL set ID: e42f6c6d-c4de-02c6-e053-2995a90a3ace
SPL ID: 0d1cde4b-4304-9c0b-e063-6394a90ac843
Version: 2
Effective date: 2023-12-22
Source export date: 2026-09-28
Source partition: 12
Source file: https://download.open.fda.gov/drug/label/drug-label-0012-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/663999d0fe1757c1e2cd13a4799d76d875f663e0bc57701092264ebe7febfc18/drug-label-0012-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 06:23:55

Harmonized routes table
Harmonized routes
ORAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 13 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M007	openfda.application_number
brand name		Mineral Oil Heavy	openfda.brand_name
generic name		MINERAL OIL	openfda.generic_name
manufacturer name		Pharma Nobis, LLC	openfda.manufacturer_name
ndc	package	82645-906-32	openfda.package_ndc
ndc	package	82645-906-16	openfda.package_ndc
ndc	product	82645-906	openfda.product_ndc
ndc11	package	82645090616	derived:openfda.package_ndc
ndc11	package	82645090632	derived:openfda.package_ndc
rxcui		311714	openfda.rxcui
spl id		0d1cde4b-4304-9c0b-e063-6394a90ac843	id
spl set id		e42f6c6d-c4de-02c6-e053-2995a90a3ace	set_id
unii		T5L8T28FGP	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings Do not take this product if you have abdominal pain, nausea, vomiting, change in bowel habits persisting more than 2 weeks, rectal bleeding or kidney failure are present, or use for a period of longer than 1 week unless directed by a doctor. Frequent or prolonged use may result in the dependence on laxatives. Do not administer to infants or young children, bedridden or aged patients unless directed by a doctor.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.